A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure

Completed · Phase 2 · Has a placebo group

Conditions studied: Hypertension

In brief

The purpose of this study is to evaluate the safety and blood pressure lowering effect of different doses of PF-00489791 in patients with mild to moderate high blood pressure

Key facts

Study ID
NCT00422461
Run by
Pfizer
People needed
135
Starts
2007-02-27
Expected to finish
2008-01-28
Last updated by the study team
2021-10-11

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.